AIIB to continue vaccine funding for developing nations in 2022

China-backed Asian Infrastructure Investment Bank (AIIB) will continue to finance developing countries acquire COVID-19 vaccines, a senior executive said on Thursday. Last year, AIIB had set up a funding facility to help public and private sectors fight the pandemic. The investment bank has approved 42 projects amounting to over $10.3 billion, as of Nov. 5. Its Crisis Recovery Facility has up to $13 billion allocated to support AIIB members and clients in withstanding economic and health impacts of the health crisis.